Name | Number of supported studies | Average coverage | |
---|---|---|---|
retina horizontal cell | 5 studies | 40% ± 10% | |
retinal rod cell | 4 studies | 49% ± 19% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 932.25 | 89 / 89 | 10% | 0.66 | 87 / 901 |
muscle | 100% | 295.17 | 800 / 803 | 0% | 0 | 0 / 0 |
heart | 98% | 257.43 | 846 / 861 | 0% | 0 | 0 / 0 |
stomach | 88% | 452.82 | 316 / 359 | 3% | 0.09 | 10 / 286 |
brain | 71% | 30.04 | 1884 / 2642 | 16% | 0.28 | 112 / 705 |
spleen | 86% | 41.64 | 208 / 241 | 0% | 0 | 0 / 0 |
prostate | 42% | 15.82 | 104 / 245 | 2% | 0.03 | 9 / 502 |
breast | 37% | 18.04 | 170 / 459 | 7% | 0.23 | 74 / 1118 |
blood vessel | 44% | 21.78 | 582 / 1335 | 0% | 0 | 0 / 0 |
esophagus | 39% | 13.71 | 560 / 1445 | 4% | 0.09 | 7 / 183 |
lung | 31% | 9.18 | 177 / 578 | 6% | 0.38 | 73 / 1155 |
pancreas | 34% | 12.72 | 111 / 328 | 2% | 0.03 | 4 / 178 |
adipose | 36% | 15.65 | 432 / 1204 | 0% | 0 | 0 / 0 |
bladder | 33% | 9.24 | 7 / 21 | 2% | 0.10 | 9 / 504 |
intestine | 27% | 8.02 | 257 / 966 | 2% | 0.04 | 9 / 527 |
thymus | 22% | 5.84 | 142 / 653 | 3% | 0.18 | 16 / 605 |
tonsil | 0% | 0 | 0 / 0 | 22% | 1.09 | 10 / 45 |
adrenal gland | 14% | 3.61 | 37 / 258 | 3% | 0.20 | 7 / 230 |
skin | 12% | 3.93 | 226 / 1809 | 5% | 0.73 | 23 / 472 |
ovary | 4% | 0.90 | 7 / 180 | 10% | 0.35 | 45 / 430 |
uterus | 5% | 1.25 | 9 / 170 | 7% | 0.24 | 30 / 459 |
peripheral blood | 7% | 2.93 | 68 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 5% | 0.79 | 4 / 80 |
liver | 1% | 0.22 | 2 / 226 | 0% | 0.00 | 1 / 406 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0030518 | Biological process | nuclear receptor-mediated steroid hormone signaling pathway |
GO_0001892 | Biological process | embryonic placenta development |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0045494 | Biological process | photoreceptor cell maintenance |
GO_0017145 | Biological process | stem cell division |
GO_0043697 | Biological process | cell dedifferentiation |
GO_0048839 | Biological process | inner ear development |
GO_1902459 | Biological process | positive regulation of stem cell population maintenance |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0019827 | Biological process | stem cell population maintenance |
GO_2000035 | Biological process | regulation of stem cell division |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_2000737 | Biological process | negative regulation of stem cell differentiation |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0032039 | Cellular component | integrator complex |
GO_0000793 | Cellular component | condensed chromosome |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0000987 | Molecular function | cis-regulatory region sequence-specific DNA binding |
GO_0043565 | Molecular function | sequence-specific DNA binding |
GO_0003707 | Molecular function | nuclear steroid receptor activity |
GO_0004879 | Molecular function | nuclear receptor activity |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0034056 | Molecular function | estrogen response element binding |
GO_0061629 | Molecular function | RNA polymerase II-specific DNA-binding transcription factor binding |
GO_0000993 | Molecular function | RNA polymerase II complex binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0008270 | Molecular function | zinc ion binding |
GO_0005496 | Molecular function | steroid binding |
Gene name | ESRRB |
Protein name | Estrogen related receptor beta Steroid hormone receptor ERR2 (ERR beta-2) (Estrogen receptor-like 2) (Estrogen-related receptor beta) (ERR-beta) (Nuclear receptor subfamily 3 group B member 2) |
Synonyms | NR3B2 ERRB2 ESRL2 |
Description | FUNCTION: [Isoform 3]: Transcription factor that binds a canonical ESRRB recognition (ERRE) sequence 5'TCAAGGTCA-3' localized on promoter and enhancer of targets genes regulating their expression or their transcription activity . Plays a role, in a LIF-independent manner, in maintainance of self-renewal and pluripotency of embryonic and trophoblast stem cells through different signaling pathways including FGF signaling pathway and Wnt signaling pathways. Upon FGF signaling pathway activation, interacts with KDM1A by directly binding to enhancer site of ELF5 and EOMES and activating their transcription leading to self-renewal of trophoblast stem cells. Also regulates expression of multiple rod-specific genes and is required for survival of this cell type (By similarity). Plays a role as transcription factor activator of GATA6, NR0B1, POU5F1 and PERM1 . Plays a role as transcription factor repressor of NFE2L2 transcriptional activity and ESR1 transcriptional activity . During mitosis remains bound to a subset of interphase target genes, including pluripotency regulators, through the canonical ESRRB recognition (ERRE) sequence, leading to their transcriptional activation in early G1 phase. Can coassemble on structured DNA elements with other transcription factors like SOX2, POU5F1, KDM1A and NCOA3 to trigger ESRRB-dependent gene activation. This mechanism, in the case of SOX2 corecruitment prevents the embryonic stem cells (ESCs) to epiblast stem cells (EpiSC) transition through positive regulation of NR0B1 that inhibits the EpiSC transcriptional program. Also plays a role inner ear development by controlling expression of ion channels and transporters and in early placentation (By similarity). .; FUNCTION: [Isoform 1]: Transcription factor that binds a canonical ESRRB recognition (ERRE) sequence 5'TCAAGGTCA-3' localized on promoter and enhancer of targets genes regulating their expression or their transcription activity. Positively regulates ESR1 transcriptional activity upon E2 stimulation. . |
Accessions | ENST00000509242.5 [O95718-1] A0A2R8Y509 ENST00000512784.6 ENST00000505752.6 [O95718-2] ENST00000509323.1 A0A2R8Y491 O95718 E7EWD9 ENST00000644823.1 ENST00000380887.7 [O95718-1] |